General Notices

• NIDCR Notice of Participation in PAR-23-182 "Accelerating Behavioral and Social Science Through Ontology Development and Use: Research Network Projects (U01 Clinical Trial Not Allowed)"
  (NOT-DE-23-015)
  National Institute of Dental and Craniofacial Research
  

• Notice of Pre-Application Webinar for the Investigator-Initiated Research in Genomics and Health Equity: RFA-HG-23-017 (R01 Clinical Trial Optional) and RFA-HG-23-018 (R21 Clinical Trial Optional)
  (NOT-HG-23-049)
  National Human Genome Research Institute
  

• Notice of Availability: Proposed Amendments to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines)
  (NOT-OD-23-162)
  Office of the Director, NIH
  

Notice of Changes to Funding Opportunities

• Notice of Change to Application Due Date and Instruction in Section IV in RFA-DA-24-007, "Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)"
  (NOT-DA-23-032)
  National Institute on Drug Abuse
  

• Notice of NICHD Participation in PAR-23-122: "Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)"
  (NOT-HD-23-024)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Changes to RFA-HL-24-010 "The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)"
  (NOT-HL-23-101)
  National Heart, Lung, and Blood Institute
  

• Notice of Change to RFA-HL-24-011 "The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)"
  (NOT-HL-23-105)
  National Heart, Lung, and Blood Institute
  

• Notice of Early Termination of PAR-21-057 "Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
  (NOT-NS-23-103)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Early Termination of PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
  (NOT-NS-23-104)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to Award Budget for RFA-NS-21-029, "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
  (NOT-NS-23-105)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Correction to Other Submission Requirements and Information in PAR-22-181 "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
  (NOT-NS-23-106)
  National Institute of Neurological Disorders and Stroke
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established cohorts (R01 Clinical Trial Optional)
  (NOT-HL-23-102)
  National Heart, Lung, and Blood Institute
  

Funding Opportunities

• NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
  (PAR-23-229)
  National Institute on Drug Abuse
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
  (PAR-23-242)
  National Cancer Institute
  Application Receipt Date(s): November 03, 2025
  
  

• NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
  (PAR-23-243)
  National Cancer Institute
  Application Receipt Date(s): November 03, 2025
  
  

• Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
  (PAR-23-245)
  National Library of Medicine
  National Institute of Mental Health
  Application Receipt Date(s): November 05, 2026
  
  

• Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
  (PAR-23-249)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): September 07, 2026
  
  

• Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
  (PAR-23-250)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): September 07, 2026
  
  

• Alcohol Health Services Research (R01 Clinical Trial Optional)
  (PAR-23-251)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): September 07, 2026
  
  

• Alcohol Health Services Research (R34 Clinical Trial Optional)
  (PAR-23-252)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): September 07, 2026
  
  

• Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
  (PAR-23-256)
  National Center for Complementary and Integrative Health
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
  (PAR-23-259)
  National Cancer Institute
  Application Receipt Date(s): January 07, 2027
  
  

• Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
  (PAR-23-264)
  National Cancer Institute
  Application Receipt Date(s): September 07, 2026
  
  

• Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
  (PAR-23-273)
  National Cancer Institute
  Application Receipt Date(s): May 07, 2026
  
  

• Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R01 Clinical Trial Not Allowed)
  (RFA-AG-24-028)
  National Institute on Aging
  Application Receipt Date(s): November 03, 2023
  
  

• Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed)
  (RFA-AG-24-029)
  National Institute on Aging
  Application Receipt Date(s): November 03, 2023
  
  

• Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional)
  (RFA-AG-24-041)
  National Institute on Aging
  Application Receipt Date(s): November 03, 2023
  
  

• Elucidating Variability of Physiologic and Functional Responses to Exercise Training in Older Adults (R01 Clinical Trial Required)
  (RFA-AG-24-045)
  National Institute on Aging
  Application Receipt Date(s): November 03, 2023
  
  

• Community-Engaged Health Equity Research in Neuroscience Initiative (R01 CT Not Allowed)
  (RFA-NS-24-006)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): February 02, 2024
  
  

• Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed)
  (RFA-NS-24-007)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
  (RFA-NS-24-021)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.